Phocaeicola vulgatus improves anxiety-like behavior by ameliorating amygdala neuroinflammation and the neurite impairment in IBS Authors: Jiacheng Wu, Jing He, Kailu Zhang, Xiaoming Liu, Pengcheng Yang, Dongke Wang, Zhiyue Xu, Wei Qian, Lei Zhang, Ziqiao Lei, Xiaohua Hou, Bai Tao Published: 2026 ABSTRACT AbstractAnxiety is highly comorbid with disorders of gut-brain interaction, including irritable bowel syndrome (IBS). The gut microbiota is implicated in both conditions, yet the underlying mechanisms remain unclear. This study aimed to elucidate the neuropathological basis of anxiety in diarrhea-predominant IBS (IBS-D) and identify potential microbiota-based therapeutic targets. Here, Mendelian randomization analysis established a bidirectional causal relationship between IBS and anxiety. In our clinical cohort, 35.85% of IBS-D patients presented with comorbid anxiety, and GAD-7 anxiety scores correlated significantly with IBS symptom severity. Resting-state functional magnetic resonance imaging (rs-fMRI) revealed that IBS-D patients with comorbid anxiety exhibited significantly altered regional homogeneity (ReHo) in nine brain regions, with the most pronounced reductions observed in the bilateral amygdala. Moreover, bilateral amygdala ReHo could effectively differentiate these patients, with receiver operating characteristic (ROC) analysis yielding area under curve (AUC) of 0.746. To investigate the underlying pathology, we established a water avoidance stress (WAS) mouse model that successfully recapitulated the anxiety-like behaviors and visceral hypersensitivity observed clinically. Critically, these phenotypes were transmissible, as recipient mice colonized with microbiota from the WAS-induced IBS-D group also developed visceral hypersensitivity and anxiety-like behaviors. Phocaeicola vulgatus was determined as a key bacterial strain significantly depleted in both our IBS-D patient cohort and the WAS-induced IBS-D mice, with its abundance negatively correlating with anxiety levels. As anticipated, IBS-D patients with lower abundance of P. vulgatus exhibited reduced amygdala ReHo and Mendelian randomization analysis identified P. vulgatus as a protective factor against anxiety. Correspondingly, therapeutic supplementation with P. vulgatus ameliorated anxiety-like behaviors in WAS-induced IBS-D mice by attenuating neuroinflammation and restoring neuronal morphology in the amygdala. In conclusion, this study provides the first evidence that P. vulgatus can alleviate anxiety in IBS by targeting amygdala-centered neuropathology, presenting a novel psychobiotic strategy for treating emotional comorbidities in disorders of gut-brain interaction.Subject terms: Biomarkers, Psychiatric disorders, Molecular neuroscience Introduction Irritable bowel syndrome (IBS) is a chronic functional intestinal disorder characterized by recurrent abdominal pain and altered bowel habits in the absence of discernible organic pathology [1, 2]. According to a global survey conducted by the Rome Foundation in 2020, IBS affects approximately 10.1% of the global population [3], imposing a significant socioeconomic and healthcare burden. Based on predominant bowel habits, IBS is clinically categorized into four subtypes: diarrhea-predominant (IBS-D), constipation-predominant (IBS-C), mixed (IBS-M), and unclassified (IBS-U). Among these, IBS-D is the most prevalent subtype, accounting for approximately 31.5% of IBS [4]. Insights into gut-brain communication have revealed the interaction between the central and enteric nervous systems, linking emotional centers of the brain with peripheral intestinal function. Accumulating evidence suggests that psychological stress or emotional responses to stress not only induce anxiety or depression, but also have an impact on gastrointestinal function [5, 6]. Indeed, anxiety has been considered as the most common psychiatric comorbidities of visceral pain in the prevalent gastrointestinal disorder, particularly in IBS [7]. However, the etiology of psychological stress-associated IBS with comorbid emotional disorders is complex, lacking reliable biomarkers, and therapeutic options are highly limited. The gut microbiota is increasingly recognized as an integral component in the complex, multifactorial pathogenesis of disordered gut-brain interaction [8, 9]. While it is well-established that psychological stress can shape the gut microbial landscape via the brain-gut-axis, growing evidence suggests that microbial alterations may reciprocally influence emotional centers. As reported, depleting the gut microbiota with broad-spectrum antibiotics induces anxiety-like behaviors in mice [10]. Moreover, gut microbiota imbalance, characterized by the expansion of detrimental taxa and loss of beneficial commensals, is closely linked to the pathogenesis of IBS and anxiety [11]. For instance, our previous study identified that the genus Fusobacterium was significantly enriched in the clinical IBS cohort as well as in both maternal separation-induced and post-inflammatory IBS rat models [12], whose abundance was positively and significantly correlated with visceral hypersensitivity across these models [12]. Mice receiving IBS-D fecal microbiota exhibited faster gastrointestinal transit and anxiety-like behavior compared to those receiving microbiota from healthy controls [13]. Neuroinflammation is a critical pathophysiological feature of anxiety [11]. Several studies have demonstrated that pro-inflammatory cytokines including TNF-α, IL-6 and IL-1β can induce anxiety-like behaviors in mice, and contrarily, suppressing these cytokines can relieve the condition [14–16]. Moreover, the expression of these pro-inflammatory cytokines is also significantly up-regulated in patients with anxiety-related disorders [17–19]. Microglia, as the resident immune cells of the central nervous system, act as pivotal sensors of gut-derived signals and metabolic byproducts. The interaction between gut microbiota and microglia drives the neuroinflammation that can impair neuronal complexity and synaptic plasticity, which are central to comorbid anxiety in IBS [20, 21]. Consequently, investigating the specific microbial taxa that trigger these microglia-mediated responses and understanding how they subsequently alter brain circuit function present a promising new target for therapeutic intervention. While the evidence linking the gut microbiota to neuroinflammation and anxiety is compelling, our understanding of the precise mechanisms in the context of IBS-related anxiety remains fragmented. A primary limitation is that the vast majority of human studies are cross-sectional in design, establishing only a correlation rather than a causal relationship between microbial dysbiosis and the neuropsychiatric symptoms of IBS [22]. To address this, Mendelian randomization (MR) analysis, which leverages genetic variants as instrumental variables, can be employed to substantiate the causal direction within the IBS-microbiota-anxiety axis. Furthermore, identifying the key microbial taxa that exert non-redundant causal or protective effects remains a significant challenge. Although previous research has highlighted several microbial candidates, their specific functional contributions often remain descriptive and inconsistent across different cohorts, likely due to the inherent functional redundancy and taxonomic diversity of the human microbiome. Consequently, there is a critical need for studies that integrate taxonomic identification with specific functional outcomes. To date, even as individual aspects of the gut-brain axis are increasingly well-characterized, it remains a formidable task to integrate genetic-based human causal inference, the resulting modulation of clinical neuroimaging signatures, and rigorous mechanistic validation in preclinical models within a single translational framework [23]. Bridging these disparate levels of biological organization is essential to finally move beyond descriptive associations and toward a more profound understanding of the microbiota-IBS-anxiety axis. In this study, we investigated the interplay between anxiety, brain function, and gut microbiota in IBS-D. MR analysis was first performed to assess the causal relationship between anxiety and IBS. Moreover, we found that patients with IBS-D exhibited higher anxiety scores, and the severity of anxiety was correlated with the severity of IBS-D symptoms. Importantly, standardized regional homogeneity (ReHo) values were reduced significantly in the bilateral amygdala in IBS-D patients with anxiety. In a water avoidance stress (WAS)-induced mouse model of IBS-D, we observed visceral hypersensitivity accompanied by anxiety-like behaviors. Further investigation revealed microglial activation and reduced neuronal complexity in the basal lateral amygdala (BLA) of WAS-induced IBS-D mice. Finally, metagenomic sequencing and full-length 16S rRNA sequencing identified a significant reduction of Phocaeicola vulgatus in IBS-D patients and mice. Furthermore, P. vulgatus was identified a protective factor to anxiety. Supplementation with P. vulgatus alleviated anxiety-like behaviors in WAS-induced IBS-D mice by mitigating neuroinflammation and restoring neuronal complexity. Materials and methods Mendelian randomization All genome-wide association study (GWAS) data used in this work are publicly accessible, no extra ethical approval or informed consent was required. Detailed data sources are provided in Table S1. To investigate the potential bidirectional association between IBS and anxiety, we performed a total of two Mendelian randomization (MR) analyses. The forward MR analyses were conducted considering IBS and IBS-D as the exposures and anxiety disorders and anxiety scores as the outcome, while the reverse-MR analyses used anxiety as the exposure and IBS as the outcome. Furthermore, to explore the functional role of specific gut microbes identified in our clinical cohort, we conducted an additional MR analysis using the abundance of Phocaeicola vulgatus as the exposure and anxiety as the outcome. The method of SNPs selection refers to previous studies with modification [24]. Single nucleotide polymorphisms (SNPs) that attained genome-wide significance (P < 5 × 10−6) and independence (linkage disequilibrium R2 value < 0.001, clumping distance = 10,000 kb) were selected as instrumental variables (IVs). Approximate F statistics were used to evaluate the instrumental intensity of the SNPs in MR (Table S2). IVs with F-statistics significantly greater than 10 were deemed free of instrumental variable bias [25]. MR analysis was performed using the “TwoSampleMR” R package v0.6.9 (available from https://github.com/MRCIEU/TwoSampleMR). Five strategies were utilized: inverse-variance weighted (IVW) with multiplicative random effects, MR-Egger, weighted median, simple mode, and weighted mode. We used the IVW method as the main analysis because it provides the most precise effect estimates and almost all MR-analysis used it as the main analysis [26]. Then, heterogeneity tests, pleiotropy tests, and leave-one-out sensitivity analyses were performed to confirm the robustness and reliability of MR analysis. Patients and healthy subjects This study enrolled a cohort of 53 patients with diarrhea-predominant irritable bowel syndrome (IBS-D) and 39 healthy controls (HC) from the Division of Gastroenterology, Wuhan Union Hospital, China. Participants were selected based on previously detailed inclusion and exclusion criteria [1, 27, 28]. The IBS-D patients had not received any treatment in the past month. The clinical characteristics of all 92 subjects are summarized in supplementary Table S5. The patients were asked to maintain a daily symptom diary to record abdominal pain intensity, stool consistency. Abdominal pain was rated on a 0–10 numerical rating scale (NRS), where 0 indicated no pain and 10 represented the worst imaginable pain. Moreover, the consistency of stool was evaluated using the standardized Bristol Stool Form Scale, which classifies the form of human feces into seven types from separate hard lumps (type 1) to entirely liquid (type 7). IBS symptom severity scale (IBS-SSS) and IBS quality of life (IBS-QoL) were also used to assess the IBS clinical symptom. The anxiety status was assessed using the general anxiety disorder-7 (GAD-7) scale with seven questions. All clinical questionnaires were administered to participants at a single time point during the initial enrollment (patient intake). This study was conducted in accordance with the principles of the Declaration of Helsinki (version Fortaleza 2013). Ethical approval was granted by the Clinical Trial Ethics Committee of Huazhong University of Science and Technology (the Approval No. of the Ethics Committee is 2021-0814), and all participants provided written informed consent. This trial was registered in Chinese Clinical Trials Registry (ChiCTR2200055171, Registered on January 2, 2022). Animal and experimental design Male C57BL/6J mice (7 weeks old) were sourced from the Experimental Animal Center of Huazhong University and housed in an air-conditioned room at 24 °C with a 12 h dark/light cycle with free access to food and water. Mice were group-housed under standard conditions to avoid the confounding effects of social isolation on behavioral testing. After a one-week acclimatization to the laboratory conditions, all experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee, Tongji Medical College, Huazhong University of Science and Technology ([2025] IACUC Number: 4742). Experiment 1: To establish a stress-induced model of IBS-D and anxiety, mice were randomly divided into two groups (N = 20 per group): the Con group and WAS group. As in previous research [29], WAS mice were placed on a small platform surrounded by 25 °C water for 1 h daily for 10 consecutive days. Con group mice underwent a sham procedure on the same apparatus but without water (timeline shown in Fig. 3A). After the 10-day intervention, fecal pellets were qualified and collected to determine fecal water content, which was calculated as 100 × [1 – (dry weight / total weight)]. Subsequently, anxiety-like behaviors were assessed using three behavioral tests (detailed below). Then, mice were anesthetized with pentobarbitone sodium and sacrificed after the assessment of visceral sensation by the abdominal withdrawal reflex (AWR). Blood serum and brain tissues were collected and stored at −80 °C for subsequent analyses. Water avoidance stress-induced mice exhibited IBS-D-like symptoms and anxiety-like behaviors. A Schematic strategy of WAS-induced mice model. B The number of fecal particles. C Fecal water content. D The AWR score and threshold. E Representative tracking plots and quantification of time spent in the center and number of center entries for the Con and WAS groups in the testing phase of OFT. F Representative tracking plots and quantification of time spent in the open arms and number of open arm entries for the Con and WAS groups in the testing phase of EPMT. G The immunofluorescent staining of Iba-1 in the BLA (scale bar: 100 μm). H The mRNA expression of CD68, TNF-α, IL-1β and IL-6 in the BLA. I Perimeter and feret’s diameter of Iba-1+ cells in the BLA. J Representative images of dendritic spines in the BLA. Scale bar: 10 μm. K Quantification of dendritic spines. L Representative image of overlaid sholl rings of pyramidal neurons in the BLA region. M Neuron dendritic complexity proximal to the soma. Values are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. Experiment 2: To investigate the potential mechanistic link between the gut microbiota and anxiety in WAS-induced mice, we performed fecal microbiota transplantation (FMT). Briefly, recipient mice (N = 15 per group) were treated for three weeks with a broad-spectrum antibiotic cocktail (ampicillin 1 g/L, vancomycin 0.25 g/L, neomycin 1 g/L, and metronidazole 1 g/L) via drinking water with water renewed every 3 days for 3 weeks, and then switched to normal drinking water for 3 days to eliminate the pharmacological effect of antibiotics [30]. Subsequently, these mice were colonized with microbiota from either the Con donors (FMT-Con group) or the WAS donors (FMT-WAS group). Booster inoculations were administered throughout the experiment [31] to offset potential founder and/or cage effects and to reinforce the donor microbiota genotype. After three weeks of colonization, the mice feces were quantified and the fecal water content was measured. Following determining behavioral tests and AWR, mice were anesthetized and sacrificed for sample collection (Fig. 4A). Phocaeicola vulgatus is the core bacterial species commonly reduced in both IBS-D patients and stress-induced IBS-D mice. A The timeline for fecal microbiota transplantation in the recipient mice pretreated with an antibiotic cocktail. B The number of fecal particles. C Fecal water content. D The AWR score and threshold. E The center time and center entries in the OFT. F The time in open arms and open arm entries in the EPMT. G MaAsLin2 was used to identify the differential species in the fecal of IBS-D patients. H Linear discriminant analysis (LDA) effect size (LEfSe) showing the most differentially significant abundant taxa enriched in microbiota from the WAS vs. Con groups. I Veen plot. J The amygdala ReHo and static results between IBS-D patients with low or high P. vulgatus abundance. Values are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. Experiment 3: P. vulgatus was supplemented to investigate its role in anxiety-like behavior in WAS-induced IBS-D mice. Briefly, mice were randomly assigned into four groups (N = 10 per group): (1) Con + Veh group; (2) Con + Pv group; (3) WAS+Veh group; (4) WAS + Pv group. Mice in the Con + Veh and WAS + Veh groups received a daily oral gavage of 200 μl vehicle control, while the Con + Pv and WAS + Pv group mice were orally administered 200 μl P. vulgatus suspended in sterile anaerobic phosphate buffer saline (PBS), 1 h prior to WAS exposure. The experimental timeline has been shown in Fig. 5C. As previously described [32], P. vulgatus (ATCC 8482) were cultured anaerobically at 37 °C for 24 h in brain–heart infusion (BHI) broth (Hopebio, China) supplemented with 5 μg/mL hemin (Hopebio, China) and 0.5 μg/mL vitamin K1 (Hopebio, China). Then, the cultures were centrifuged (4000 rpm, 15 min) and resuspended in sterile anaerobic PBS to a final concentration of 1 × 109CFU per 200 μL. The dosage of P. vulgatus was selected based on prior studies that P. vulgatus orally every day with a final concentration of 5 × 109 CFU per milliliter can significantly alleviate dextran sulfate sodium salt (DSS)-induced colitis and lipopolysaccharide (LPS)-induced depression in mice [32, 33]. On day 16 of the experimental timeline, following the completion of behavioral testing, fresh fecal pellets were collected to quantify P. vulgatus abundance, after which the mice were sacrificed. Phocaeicola vulgatus ameliorates anxiety-like behavior in WAS-induced IBS-D mice. A After controlling for age, gender, and BMI, a generalized linear model was applied to determine the correlation between P. vulgatus and GAD-7 scores. B The spearman’s correlation between the abundance of P. vulgatus and behavior tests. C Scatter plot. D Schematic strategy of P. vulgatus supplement experiment. E The relative abundance of P. vulgatus in mice feces. F The representative track plots of the Con and WAS groups in the testing phase of OFT and EPMT. G The center time, center entries and total distance in the OFT. H The time in open arms, open arm entries and total distance in the EPMT. Values are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. Behavioral tests To investigate the anxiety-like behaviors of mice, behavioral tests were conducted, including the open-field, elevated plus maze, and light-dark box tests. The procedures followed were comparable to those described in earlier studies [11, 34]. Investigators were blinded to the group allocation during behavioral assessments and data analysis. Open-field test The open-field test OFT was conducted in a square open-air arena (70 cm × 70 cm × 70 cm). Prior to testing, mice were acclimated to the experimental room for approximately one hour. After habituating the box without recording for 5 min, each mouse was then placed in the center of the arena and allowed free exploration for 5 min. A video camera positioned above the arena captured all mouse movements. To eliminate olfactory cues, the box was thoroughly cleaned with 75% ethanol after each trial. Total distance traveled, number of times passed through the central area, and time spent in the central area of box was measured. Elevated plus maze test The elevated plus maze consists of two open and two closed arms radiating from a central area. In the elevated plus maze test (EPMT), each mouse was placed in the center, facing an open arm, and allowed to explore the maze freely for 5 min. Mouse activity was video-recorded and the maze was cleaned with 75% ethanol before each trial to remove residual odors. The total distance traveled, the number of open arm entries and the time spent in the open arms were subsequently measured. Light-dark box The light-dark box apparatus was composed of a brightly lit chamber and an equally sized dark chamber, connected by a small opening. Each mouse was initially placed in the lit area and its activity was recorded for 10 min. Two parameters were quantified by a blinded observer: the duration spent in the light compartment and the total number of transitions between chambers. The sample sizes of behavior tests were based on the calculations using power analysis at a significance level of α = 0.05 (two-sided) and the power of 1 − β = 80%.The sample size N = 20 for each group was estimated based on the data of three behavior tests in the previous intervention [35–37]. Specifically, for the OFT, this sample size achieves a power of 0.9880 for center time based on expected means of 40 and 20 with a standard deviation (SD) of 15, and a power of 0.9880 for center entries given means of 35 and 15 with a SD of 15. In the EPMT, the power reaches 0.9990 for open arm time with means of 28 and 12 and a SD of 10, while open arm entries achieve a power of 0.9667 based on means of 48 and 42 with a SD of 5. For the light-dark box, time in the light chamber yields a power of 0.9973 given means of 18 and 6 and a SD of 8, and light-dark transitions achieve a power of 0.9947 with means of 10 and 5 and a SD of 3.5. Calculation method is on website https://powerandsamplesize.com/calculators/. For Experiments 2 and 3, the sample sizes of N = 15 and N = 10 per group, respectively, were also meet the standard mentioned above. Immunofluorescence staining Following transcardial perfusion, mouse brains were collected, fixed in 4% paraformaldehyde (G1101, Servicebio, China) for 24 h, and then immersed in a 30% sucrose solution for two days. The brains were sectioned into 20 µm-thick frozen sections using a cryostat at −18 °C. For staining, the sections were blocked with 1% BSA for 40 min at 37 °C and subsequently incubated overnight at 4 °C with a primary antibody against Iba1 (ionized calcium-binding adapter molecule 1; 1:500, #019-19741, Wako). Then, the secondary antibody goat anti-rabbit Alexa Fluor 488 was applied to detect the corresponding primary antibodies. Finally, nuclei were counterstained with DAPI (G1012, Servicebio), and images were captured using a fluorescence microscope (OLYMPUS IX51). The immunoreactivity of Iba1 in each field was quantified using ImageJ software. Shotgun metagenomic sequencing Full stool samples were collected from each participant using home stool collection kits. Participants were instructed to store the samples in a freezer immediately after collection until they were either dropped off to a study coordinator or picked up by a courier service within 24–48 h. Upon receipt, the samples were promptly transferred to laboratory freezers for long-term storage at −80 °C until further use, and any necessary shipment was conducted on dry ice within a 48 h duration to maintain microbial integrity. Shotgun metagenomic sequencing was conducted at Maintain Biotech (Wuhan, China). Sequencing libraries were prepared according to Illumina’s protocol, with 200 μg of genomic DNA fragmented by Covaris to an average size of 300–350 bp. The fragments underwent end repair, phosphorylation, and A-tailing, followed by adapter ligation. After size selection and PCR amplification, the prepared libraries were sequenced on an Illumina NovaSeq PE150 System (Illumina Inc., San Diego, CA, USA). Raw paired-end reads were initially trimmed and filtered using FASTP (version 0.23.2) [38]. Reads containing more than 10 ambiguous or undetermined base calls, having a mean quality score less than 30, or with a length smaller than 90 nt after trimming were removed. The trimmed and quality-controlled reads were then host-filtered using BBSplit from BBMap (version 38.99, https://sourceforge.net/projects/bbmap/) to remove human DNA mapped to hg38. Bacterial taxonomic profiling of the preprocessed metagenomes was performed using MetaPhlAn4 (version 4.0.6) with the mpa_vOct22_CHOCOPhlAnSGB_202212 database [39]. Full-length 16S rRNA sequencing Full-length 16S rRNA sequencing was conducted at Maintain Biotech (Wuhan, China). Fecal sample collection, and DNA extraction were performed as previously described [27]. Specifically, fresh fecal pellets were collected under aseptic conditions by temporarily placing each mouse in an individual sterile cage, after which samples were immediately snap-frozen and stored at −80 °C until DNA extraction. The full-length 16S rRNA (V1-V9 regions) of bacteria was PCR amplified using the universal bacterial primers 27 F 5′-AGAGTTTGATCCTGGCTCAG-3′ and 1492 R 5′-GGTTACCTTGTTACGACTTO-3′. The raw FAST5 data of full-length 16S sequences from Nanopore sequencing was processed using the PacBio SMRT portal (PacBio, Menlo Park, CA, USA) for initial analysis. Amplicons were trimmed on the PacBio platform to discard sequences outside the expected amplicon size range. Taxonomic classification was then assigned based on the Mothur algorithm, referencing the SSUrRNA Database of Silva Database (version 138.1). Gut microbiota analysis The relative abundance of each taxon was computed by normalizing the number of assigned reads to the number of total reads sequenced, and the average abundance of each group was calculated. To estimate the alpha diversity of the microbiota, several indices, including community richness (observed species), community diversity (Shannon and Gini-Simpson indices), and community evenness (Pielou’s index), were calculated using the vegan R package (version 2.7-2) as previously described [27]. Furthermore, beta diversity was estimated under the Bray–Curtis distance and was calculated using the vegan R package and represented through principal coordinate analysis (PCoA). Moreover, permutational multivariate analysis of variance (PERMANOVA) based on the Bray-Curtis distance with 999 permutations was employed to evaluate dissimilarities in microbial community composition using the R package pairwise.adonis (version 0.4.1) [40], with P-values adjusted for multiple testing via the Benjamini-Hochberg (BH) correction. Principal component analysis (PCA) graphs were plotted in using prcomp function, and PCs were visualized using plotly package (version 4.11.0). Multivariate general linear regression model was employed to identify differential bacteria between IBS-D and HC individuals. Linear model was established using the MaAsLin2 package (version 1.8.0) [41], with age, gender, and BMI adjusted as covariates. Furthermore, linear discriminant analysis (LDA) Effect Size (LEfSe) analysis was performed to detect the features of gut microbiota with significant difference in abundance between designated taxa in WAS-induced mice with the Kruskal−Wallis rank sum test, which was performed using the microeco R package (version 1.16.0) [42, 43], with LDA score ≥2.5 as the threshold. Receiver operating characteristic curve analysis The ability of amygdala ReHo to predict anxiety in IBS-D patients and abundance of fecal P. vulgatus to predict IBS-D were assessed with receiver operating characteristic (ROC) curve analyses. Further, machine learning prediction models were constructed using the lateral amygdala ReHo as predictive features via the caret package (version 7.0-1) [44]. To predict the probability of having anxiety in IBS-D patients, a leave-one-out cross-validation (LOOCV) predictive implementation was employed to generate probability of comorbid anxiety for each participant. Specifically, for a cohort of N participants, the model was iteratively trained on N-1 individuals and tested on the single remaining participant. This process was repeated N times until a cross-validated prediction probability was generated for every participant. The performances of each individual signature and the prediction models were quantified using the AUC (area under the curve) of the ROC for classification. R package pROC (version 1.19.01) [45] was utilized for ROC curve analyses. Quantitative reverse transcription polymerase chain reaction (RT-qPCR) The qPCR procedures were carried out in accordance with previously established methods [24, 46, 47]. Briefly, total RNA was extracted with RNA Isolator Total RNA Extraction Reagent (Vazyme, China) from the amygdala tissues, before reverse-transcription to cDNA using a HiScript II Q RT SuperMix for qPCR (+gDNA wiper) kit (Vazyme, China). The qPCR analysis was conducted with the aid of the SYBR GREEN Master Mix (TaKaRa, Japan) on a real-time PCR detection system (Roche LightCycler480, Switzerland). The mRNA levels for specific genes were calculated using the formula 2−ΔΔCT and normalized by β-actin mRNA level. All primer sequences used in the present study are provided in Table S4. Enzyme-linked immunosorbent assay (ELISA) The concentration of corticosterone (E-OSEL-M0001, Elabscience, China) and 5-HT (E-EL-0033, Elabscience, China) was quantified by using a commercially available ELISA kit according to the manufacturer’s instructions. See “Additional files” section for detailed information of procedures (“Fecal microbiota transplantation”, “Abdominal withdrawal reflex”, “Bacterial quantification in feces”, “Golgi-Cox staining”, “Real-time PCR to quantify P. vulgatus”, “Blood–brain barrier permeability assays”, “Magnetic resonance imaging visits”, “Resting-state fMRI data processing”, “DKI data processing”). Statistical analysis All data are presented as the mean ± standard error of the mean (SEM). Statistical analyses were performed using GraphPad Prism software 10.0. Data normality was first assessed with the Shapiro-Wilk test. For comparisons between two groups, a Student’s t-test was used, and Cohen’s d was calculated to determine the effect size. For comparisons among multiple groups, a one-way analysis of variance (ANOVA) followed by the Tukey-Kramer post hoc test was employed. The relative abundances of the specific taxon between different groups were calculated using the Wilcoxon rank-sum test. A P value <0.05 was considered statistically significant. Results Altered amygdala function is associated with the anxiety comorbidity in patients with IBS-D Previous studies have linked IBS with psychiatric disorders [48, 49], including anxiety. Here, Mendelian randomization (MR) analysis was used to determine the potential relationship between IBS and anxiety disorders independent of environmental or self-adopted confounding factors (Tables S1–S3). As expected, IBS was linked to a higher risk of anxiety disorders and anxiety score with the inverse variance weighted (IVW), and weighted median methods (Fig. 1A-C). In the case of significant heterogeneity (P < 0.05), we used random effects models. Moreover, we found positive causal relationships between IBS-D and anxiety disorders with the IVW method (Fig. 1A, D). Furthermore, bidirectional MR was used to investigate the inverse causal effects of anxiety on IBS, and found that anxiety score was positive associated with IBS with the IVW method (Fig. 1A, E). In addition, pleiotropy tests indicated P > 0.05 (Table S3), supporting the robustness of these findings. We also performed leave-one-out sensitivity for each SNP analysis, which showed that the causal association between exposure and outcome did not change due to the influence of a single SNP, and all lines were located to the same side of 0 (Fig. S1A-E). Associations between IBS and anxiety. A Forest plot. B-E Scatter plot. CI confidence interval, OR odds ratio, SNP single nucleotide polymorphism. To further explore the relationship between anxiety and IBS, we established a cohort of patients with IBS-D and found that they exhibited significantly higher GAD-7 anxiety score (Fig. 2A). Except BMI, the characteristics of age and gender were balanced between the groups (Table S5). Furthermore, in our cohort, 35.85% of patients with IBS-D presented with comorbid anxiety symptoms (Fig. 2B). Spearman correlation analysis revealed that GAD-7 score was positively correlated with abdominal pain (NRS), total IBS-SSS total score, IBS-SSS abdominal pain severity and IBS-SSS impacts on daily life, but negatively correlated with IBS-QoL score in patients with IBS-D (Fig. 2C). In summary, these findings indicate that anxiety is closely associated with IBS-D and its symptoms. Altered amygdala function is a key characteristic of IBS-D patients with comorbid anxiety. A GAD-7 score. B The dot plot shows the proportion of IBS-D patients with comorbid anxiety. C The spearman’s correlation analysis. D, E The differential region of ReHo between IBS-D patients with and without anxiety. F The amygdala ReHo. G Cohen’s d effect size. H The ROC curve. Next, rs-fMRI was utilized to further investigate the changes in brain function that mediate anxiety in patients with IBS-D. To measure spontaneous brain activity, we utilized Regional Homogeneity (ReHo) (Fig. S2A). Conceptually akin to a nearest-neighbor clustering method applied to temporal dynamics, ReHo evaluates the temporal synchronization of the blood oxygen level-dependent (BOLD) signal between a given voxel and its immediate surrounding neighbors, thereby directly reflecting local functional coherence and microcircuitry dynamics. T-tests revealed significant ReHo alterations in 9 brain regions in IBS-D patients with anxiety (Fig. S2B). After adjusting for age, sex, and BMI, general linear model observed 6 brain regions significantly associated with anxiety in IBS-D patients (Fig. 2D and Table S6). Notably, the bilateral amygdala were the brain regions exhibiting the most pronounced alterations in patients with IBS-D and comorbid anxiety (Fig. 2E-G, S2C). Additionally, the ReHo parameters of the left and right amygdala served as robust biomarkers for identifying anxiety, with respective AUCs of 0.736 and 0.763 (Fig. 2H). Further, machine learning prediction model was established using the lateral amygdala ReHo, which could effectively predict anxiety in IBS-D with an AUC of 0.746 (Fig. 2H). Furthermore, we performed Diffusional Kurtosis Imaging (DKI) on the bilateral amygdala in patients with anxiety. We found no significant differences in structure-related parameters (AD, AK, FA, KFA, MD, MK, MKT, RD, and RK) compared to non-anxious IBS-D patients (Fig. S3). In summary, these findings indicate that reduced ReHo function in the amygdala is the core cerebral alteration in IBS-D patients with comorbid anxiety. Stress induces visceral hypersensitivity and anxiety-like behavior in mice Next, water avoidance stress (WAS) mice model was used to further investigate the relationship between IBS-D and anxiety (Fig. 3A). A significant increase in serum corticosterone, a stress-related hormone, was observed in the stressed mice (Fig. S4A). Moreover, the number of fecal particles excreted during 1 h was increased significantly in WAS mice (Fig. 3B). Also, the fecal water content of WAS mice was similarly elevated (Fig. 3C). Importantly, compared with Con group, the AWR score for WAS mice increased at pressures of 40 and 60 mmHg (Fig. 3D). Consistently, WAS mice exhibited a decreased pain threshold (Fig. 3D), indicating the presence of visceral hypersensitivity. After we determined the IBS-like behavior in WAS mice, three behavior tests were performed to investigate the anxiety-behavior of mice. There was no significant difference in the light-dark box test between Con and WAS group mice (Fig. S4B, C). In the OFT, WAS mice demonstrated decreased center times and center entries (Fig. 3E). In the EPMT, WAS mice demonstrated decreased time in the open arm and open arm entries (Fig. 3F). However, there was no significant difference in the total distance traveled by the mice in the OFT and the EPMT (Fig. S4D, E). In summary, these results indicate that stress-induced IBS-D mice exhibit anxiety-like behavior. Microglia-mediated neuroinflammation and reduced neuronal complexity constitute the key role for comorbid anxiety-like behavior in IBS-D mice Neuroinflammation in the amygdala is considered to be involved in the neuropathological mechanisms of anxiety [11, 50]. Following our observation of functional alterations in the bilateral amygdala of IBS-D patients with anxiety, we further characterized the microglial profile in the basolateral amygdala (BLA) of stress-induced IBS-D mice. Compared with the Con group, the number of Iba1+ cells (microglia marker) was significantly increased in the WAS group (Fig. 3G). Moreover, mRNA expression of the activated microglial marker CD68 was significantly higher in the WAS mice than the Con group mice (Fig. 3H). Correspondingly, the majority of Iba1+ cells in the WAS group showed the morphology of activated microglia, which was evidenced by decreased perimeter, feret’s diameter (Fig. 3I), and increased circularity (Fig. S5A), solidity (Fig. S5B) indices. Furthermore, the mRNA expression of pro-inflammatory cytokines TNF-α and IL-6 was significantly elevated in WAS group mice (Fig. 3H). There was no significant difference in the IL-1β mRNA levels between WAS and Con groups (Fig. 3H). Dysfunction of the blood-brain barrier (BBB) has been closely associated with microglia-mediated neuroinflammation, which is a key pathomechanism underlying the onset and progression of disordered gut-brain interaction [51]. Notably, we observed a significant increase in Evans blue extravasation in the amygdala of WAS mice compared to control mice, providing direct evidence of BBB disruption (Fig. S5C). Moreover, neurite impairment associated with activation of microglia is a typical neuropathological feature for anxiety disorders [52]. Therefore, we further detected neurite arborization in the amygdala of mice. Using Golgi-Cox staining, we observed significantly lower spine density (Fig. 3J, K) and reduced neuritic branches in WAS mice (Fig. S5D). Furthermore, sholl analysis showed that the sum intersection (10~300 μm from the soma), the number of dendritic intersections, and the max intersections distance from soma declined in the WAS group, compared with the Con group (Fig. 3L, M and S5E-G). In summary, the results indicate the presence of neuroinflammation and neurite impairment in the amygdala of stress-induced IBS-D mice. Gut microbiota mediates the anxiety-like behavior in IBS-D mice Acknowledging the established link between the gut microbiota, IBS-D, and its comorbid anxiety [53, 54], our subsequent experiments employed fecal microbiota transplantation (FMT) to further investigate their potential associations. C57BL/6J mice underwent antibiotic pretreatment to induce a pseudo-germ-free state (Fig. 4A), confirmed by an approximately 10-fold reduction in fecal bacterial load compared to non-antibiotic-treated controls (Fig. S6A). Recipient mice then received microbiota from either WAS-exposed or control donors. Intriguingly, colonization with WAS-derived microbiota transferred an IBS-like phenotype (Fig. 4B-D), characterized by accelerated colonic transit (increased 1-h fecal pellet count), diarrhea (elevated fecal water content), and visceral hypersensitivity (higher AWR scores at 40 and 60 mmHg colorectal distension). Crucially, the anxiety-like phenotype was transmissible via the gut microbiota. Recipient mice colonized with microbiota from the WAS group (FMT-WAS) exhibited significant anxiety-like behaviors compared to those receiving control microbiota (FMT-Con). Specifically, in the OFT, the FMT-WAS group spent less time in and made fewer entries into the central area (Fig. 4E). Similarly, in the EPMT, these mice showed a significant reduction in both the time spent in and entries into the open arms (Fig. 4F). Collectively, these results demonstrate that the gut microbiota is a key mediator of anxiety-like behaviors in the IBS-D mouse model. Phocaeicola vulgatus is a key species in IBS-D patients and is closely associated with anxiety Next, we characterized the profile of gut microbiota in the human IBS-D population using shotgun metagenomic sequencing, with the aim of identifying specific bacterial species that hold promise for alleviating their comorbid anxiety. Alpha diversity indices, including the Shannon, Pielou’s evenness, and Gini-Simpson indices, were significantly reduced in patients with IBS-D, with the exception of observed species (Fig. S7A). Furthermore, there was a considerable separation between IBS-D and HC samples in PERMANOVA analysis (R2 = 0.033, adjusted P < 0.001) and PCoA score plot (Fig. S7B). Next, the relative abundance of taxa was calculated and the top 10 most abundant phyla, genera and species has been demonstrated (Fig. S7C-E). In addition, multivariable association analysis using MaAsLin2 was applied to examine microbial differences between IBS-D and HC while adjusting for potential confounders, identifying 32 significantly differential genera (Table S7). Notably, 21 bacterial species were downregulated and 11 were upregulated in the feces of IBS-D patients. Among these, P. vulgatus was the most significantly depleted species, with a coefficient of −5.001 (Figs. 4G and S7F). Furthermore, to parallel our clinical findings, the fecal microbiota of stress-induced IBS-D mice was independently characterized using full-length 16S rRNA sequencing. The PCoA score plot based on bray-curtis distance has been demonstrated (Fig. S8A). Additionally, the PCA plot revealed a significant separation between the fecal microbiota of the WAS and Con groups (Fig. S8B). The relative abundance of taxa was calculated and the top 10 most abundant phyla and species has been demonstrated (Fig. S8C, D). Then, LEfSe analysis (LDA score ≥2.5 as threshold) was used to further screen the significant disparities in microbial taxa, revealing lower abundance of Dorea longicatena, Rikenella microfusus, Proteiniclasticum ruminis, P. vulgatus and Muribaculum intestinale at species level in IBS-D patients (Fig. 4H). Furthermore, linear modeling identified 9 up-regulated species and 3 down-regulated species in the fecal microbiota of WAS mice (Fig. S8E). Importantly, P. vulgatus was a key bacterial species found to be commonly depleted in both IBS-D patients and stress-induced IBS-D mice (Figs. 4I and S8F), which provided a translational link between our clinical and preclinical findings. To further investigate the relationship between P. vulgatus and amygdala function, the 41 patients with IBS-D who underwent both fecal metagenomic sequencing and brain fMRI were dichotomized into high- and low-abundance groups based on the median fecal abundance of P. vulgatus. Importantly, patients with IBS-D characterized by a low abundance of P. vulgatus showed significantly lower ReHo values in the amygdala (Figs. 4J and S7G). Similarly, we performed a median split on the amygdala ReHo values to stratify patients into a low-ReHo group and a high-ReHo group. Interestingly, we found a substantial overlap between these two groupings: 71.43% of patients in the low P. vulgatus abundance group also fell into the low amygdala ReHo group (Fig. S7H). Consistently, 70% of patients in the high P. vulgatus abundance group were also classified as having high amygdala ReHo (Fig. S7H). Concurrently, P. vulgatus abundance showed a modest ability to differentiate IBS-D patients, with an AUC of 0.602 (Fig. S7I). In summary, our results establish an intricate link between P. vulgatus abundance and amygdala function in IBS-D, highlighting this bacterium as a promising therapeutic candidate for mitigating anxiety comorbidity in IBS-D. P. vulgatus attenuates amygdala neuroinflammation, neurite impairment and anxiety-like behavior in WAS-induced IBS-D mice Given the reduction of P. vulgatus in both IBS-D patients and mice, along with its significant correlation with amygdala ReHo, we further explored and found that the abundance of P. vulgatus was significantly and negatively correlated with GAD-7 anxiety scores in IBS-D individuals (Fig. 5A). Consistent with the clinical findings, the relative abundance of P. vulgatus in IBS-D mice was significantly correlated with anxiety-like behaviors in the OFT and EPMT (Fig. 5B). Moreover, the MR analysis provided robust genetic evidence for a protective causal effect of P. vulgatus abundance on anxiety risk (IVW: OR = 0.7575, 95% CI: 0.6138–0.9348, P = 0.0096; Figs. 5C, S1F, and Table S8). Specifically, an increase in the genetically-predicted abundance of P. vulgatus was associated with a lower risk of anxiety, supporting its role as a protective factor rather than a risk factor. Next, the effects of P. vulgatus supplement on stress-induced anxiety-like behavior in IBS-D mice were investigated (Fig. 5D). To begin with, oral gavage P. vulgatus significantly increased its abundance in mice fecal (Fig. 5E). Furthermore, serum 5-HT levels were significantly increased in WAS mice, while administration of P. vulgatus tended to reduce these elevated levels (Fig. S9). Importantly, supplementation with P. vulgatus significantly increased both the time spent and the number of entries into the central zone of the OFT in stress-induced IBS-D mice (Fig. 5F, G). Consistently, supplementation with P. vulgatus also increased the time spent in and the number of entries into the open arms of the EPMT in stress-induced IBS-D mice (Fig. 5F, H). Overall, these results indicate that supplementation with P. vulgatus can alleviate anxiety-like behavior in stress-induced IBS-D mice. Next, we found that supplementation with P. vulgatus reduced the number of activated microglia (Fig. 6A, B) and downregulated the mRNA levels of the pro-inflammatory cytokines TNF-α and IL-6 in the BLA of WAS mice (Fig. 6C-E). Moreover, sholl analysis showed that the number of neurite branches, the maximum number of intersections, and the sum intersection (10~300 μm from the soma) were increased in the WAS group supplemented with P. vulgatus (Fig. 6F-K). Consistently, higher spine density was observed in WAS mice supplemented with P. vulgatus (Fig. 6L, M). In summary, the results indicate P. vulgatus is associated with attenuated amygdala neuroinflammation and neurite impairment, contributing to the alleviation of anxiety-like behavior in stress-induced IBS-D mice (Fig. 7). Phocaeicola vulgatus ameliorates neuroinflammation and neurite deficits in WAS-induced IBS-D mice. A The immunofluorescent staining of Iba-1 in the BLA (scale bar: 100 μm). B-E The mRNA expression of CD68, TNF-α, IL-1β and IL-6 in the BLA. F The number of neurite branches. G, K Neuron dendritic complexity proximal to the soma. L, M Spine density and representative images spines in the BLA. Values are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001. Phocaeicola vulgatus ameliorates neuroinflammation and the neurite impairment in the amygdala to improve anxiety-like behavior. Discussion Anxiety is a primary psychiatric comorbidity in IBS-D, and our research establishes a bidirectional causal relationship between the two conditions. The most striking brain alteration identified in IBS-D patients with comorbid anxiety was dysregulated function in the bilateral amygdala. These clinical findings were recapitulated in a stress-induced mouse model, which displayed both visceral hypersensitivity and anxiety-like behaviors driven by microglia-mediated neuroinflammation and neuronal damage in the basolateral amygdala. Interestingly, the anxiety-like behaviors characteristic of the WAS-induced IBS-D model were successfully recapitulated in mice that received FMT, which provides compelling evidence for the initiating role of the gut microbiota in the pathogenesis of anxiety-like behaviors in IBS-D. Importantly, we provide the first causal evidence via Mendelian randomization that P. vulgatus protects against anxiety, a finding corroborated by its significant negative correlation with both anxiety symptoms and amygdala function in our IBS-D cohort. Furthermore, supplementation with P. vulgatus ameliorated not only the anxiety-like behaviors but also the underlying amygdala neuropathology in the mouse model. In conclusion, our study not only elucidates the central nervous system alterations associated with comorbid anxiety in IBS-D, but also proposes a novel therapeutic strategy based on peripheral intervention. This work provides a new conceptual framework and a promising avenue for treating the affective disorders in patients with IBS-D. As a central integrative hub within the microbiota-gut-brain axis, the amygdala synthesizes widespread sensory and visceral information to orchestrate emotional well-being and pain perception [55]. Due to this critical integrative function in encoding and modulating pain and affective states, the amygdala acts as a primary convergence point in the microbiota-gut-brain axis, playing a vital role in the development and progression of IBS [56]. Despite extensive investigation, the specific nature of amygdala alterations in IBS remains incompletely understood. While some studies report heightened amygdala activation and connectivity correlating with symptom severity and emotional dysregulation [48, 57], others suggest variability influenced by factors such as sex, psychological comorbidities, and IBS subtypes [58, 59]. By analyzing patients specifically with IBS-D and adjusting for clinical variables, we identified that the most striking neuroimaging characteristic of those with comorbid anxiety was a significant reduction in ReHo within the bilateral amygdala. Building upon these findings, our ROC analysis further demonstrated that these neural alterations possess considerable potential for the differential diagnosis of anxiety within the IBS-D population, with the combined bilateral amygdala model yielding a robust AUC of 0.746. However, it is noteworthy that the ROC curves exhibited partial overlap with the 0.5 diagonal line at certain thresholds. This suggests that while amygdala-based functional markers are highly indicative of emotional dysfunction in IBS-D, the inherent biological heterogeneity among patients means that certain diagnostic cut-offs may yield a trade-off between sensitivity and specificity. Thus, these neuroimaging signatures may be most effective when integrated into a multi-dimensional diagnostic framework rather than being used as standalone markers. While prior research has largely been confined to correlational observations of amygdala alterations in IBS and anxiety, our study significantly extends this knowledge. We not only explored the causal link between IBS and anxiety using Mendelian randomization but also developed a translational IBS-D mouse model that accurately mimicked the clinical and behavioral manifestations. Crucially, our preclinical findings provided mechanistic underpinning, demonstrating neuroinflammation and reduced neuronal complexity in the amygdala, thereby validating the observed decrease in amygdala ReHo in anxious IBS-D patients. The gut microbiota is deeply intertwined with anxiety via the gut-brain axis [11]. In our study, P. vulgatus emerged as a key bacterium of interest, not only identified as a causal protective factor against anxiety via Mendelian randomization but also found to be significantly reduced across both IBS-D patients and the analogous mouse model. Moreover, the successful induction of anxiety-like behaviors following FMT from IBS-D donors underscores the causative role of microbial dysbiosis, validating the microbiota as a viable therapeutic target. Consistent with previous findings that P. vulgatus administration ameliorates anxiety-like behaviors in DSS-induced colitis mice [32], we demonstrated that oral supplementation with this bacterium effectively alleviated anxiety in our IBS-D model. Mechanistically, while our data clearly show that P. vulgatus reduces amygdala neuroinflammation and rescues neuronal complexity, the precise molecular messengers mediating this central effect require further exploration. Given that P. vulgatus is a primary producer of short-chain fatty acids (SCFAs), and prior research confirms its ability to increase fecal propionate and butyrate [33, 60], its anxiolytic properties may be largely metabolite-driven. Furthermore, butyrate administration has been shown to improve anxiety symptoms in lead-exposed mice [61]. However, despite its promising therapeutic efficacy, the clinical translation of P. vulgatus must be approached with rigorous safety evaluations due to its dual nature as both a beneficial commensal and an opportunistic pathogen [62, 63]. In vulnerable populations such as IBS-D patients, who frequently present with compromised intestinal barrier integrity, the administration of live opportunistic bacteria carries a potential risk of translocation, which could lead to severe systemic infections like sepsis. Therefore, future translational efforts must carefully navigate these pathogenic risks. If the neurological benefits of P. vulgatus are indeed driven by its metabolic output, exploring non-viable bacterial derivatives or specific protective metabolites, collectively termed postbiotics, presents a highly attractive and safer alternative. Although live probiotic therapies theoretically offer sustained, localized metabolite production, they are often hindered by transient colonization and intrinsic safety concerns[64, 65]. By contrast, the direct delivery of specific postbiotics, such as targeted SCFAs formulations, circumvents these colonization hurdles while harnessing the identical neurological benefits. Consequently, developing precision delivery systems for these specific microbial metabolites warrants comprehensive investigation as a promising therapeutic avenue for managing IBS-D with comorbid anxiety. Neuroinflammation in the amygdala is an established neuropathological basis for anxiety [50]. Our study identified compelling evidence of this process in stress-induced mice, beginning with microglia, the brain’s resident immune cells [66]. While the number of microglia in the BLA increased post-stress, we focused on morphological changes as a more definitive indicator of neuroinflammation, since microglia quantification may be not a typical feature of neuroinflammation [67]. We observed hypertrophic cell bodies and increased circularity and solidity in Iba1+ cells, which are clear hallmarks of microglial activation [68]. This activated state was functionally linked to significantly elevated mRNA expression of pro-inflammatory cytokines IL-6 and TNF-α, both known to induce anxiety in mice [11, 69]. Beyond neuroinflammation, the neuronal complexity of the amygdala is intricately linked to anxiety. Previous research has found that adult male Wistar rats subjected to repeated mild traumatic brain injuries exhibited anxiety-like behaviors and reduced neuronal complexity in the basolateral amygdala [70]. Consistent with previous findings, our stress-induced mice exhibited reduced neuronal complexity in the amygdala. Crucially, supplementation with P. vulgatus not only reversed these neuronal alterations but also alleviated anxiety-like behaviors. While our current findings highlight the amygdala as a focal point, it is highly plausible that these neuroprotective effects extend to other interconnected cortical and subcortical regions within the emotional regulatory circuit. Furthermore, future research should aim to delineate the precise spatial topography of these microbial effects across the whole brain and elucidate the underlying cellular and molecular mechanisms, potentially mediated by specific microbial metabolites, to develop precise microbiota-based therapies for IBS with comorbid anxiety. Despite these promising findings, several limitations in the present study should be acknowledged. First, the clinical cohort in our study is cross-sectional in design. While we identified robust correlations among P. vulgatus abundance, amygdala functional alterations, and anxiety symptoms in IBS-D patients, these observational data cannot establish definitive causality in humans. Although we employed MR and murine models to provide causal and mechanistic insights, future longitudinal clinical studies with larger, multicenter cohorts are warranted to validate the temporal dynamics of these microbiota-gut-brain interactions. Second, while we demonstrated that P. vulgatus supplementation alleviates anxiety-like behaviors by reducing amygdala neuroinflammation, the specific gut-derived molecular mediators, such as specific SCFAs or other immune signals, that cross the BBB remain to be fully elucidated. Finally, our mechanistic investigation primarily focused on the basolateral amygdala based on our clinical neuroimaging results. Given the complexity of the gut-brain axis, it is highly plausible that these neuroprotective effects extend to other interconnected cortical and subcortical regions within the emotional regulatory circuit, necessitating whole-brain spatial assessments in future studies. Furthermore, while our current study primarily compared IBS-D patients to healthy controls to identify global microbial alterations, future investigations would greatly benefit from comparing IBS-D patients with and without comorbid anxiety in a new, adequately powered clinical cohort. Such an intra-disease control design would more effectively uncouple the microbial signatures specific to bowel dysfunction from those driving psychiatric comorbidities. Nevertheless, although P. vulgatus was initially screened via the IBS-D versus healthy control comparison, its specific role in modulating emotional states is strongly supported in our study by its significant negative correlation with GAD-7 anxiety scores and amygdala function within the IBS-D cohort, alongside robust causal and mechanistic evidence from MR and preclinical models. Conclusions In conclusion, by integrating clinical and preclinical evidence, our study demonstrates that the gut microbiota plays a pivotal, causal role in mediating anxiety-like behaviors and amygdala dysfunction in IBS-D. In present study, we first investigated the bidirectional causal relationship between IBS and anxiety using Mendelian randomization. Furthermore, pseudo-germ-free mice that received fecal microbiota transplantation from IBS-D mice exhibited anxiety-like behaviors, suggesting an initiating role for the gut microbiota in IBS-D-associated anxiety. Notably, we identified Phocaeicola vulgatus as a key protective species through Mendelian randomization, a finding strongly corroborated by its depletion in IBS-D patients and its direct correlation with the normalization of amygdala function. Critically, in our preclinical model, supplementation with P. vulgatus ameliorated anxiety-like behaviors by reversing key amygdala pathologies, including neuroinflammation and neuronal damage. This work provides compelling proof-of-concept for a novel therapeutic paradigm: targeting a specific peripheral microbe to treat a central nervous system comorbidity. Our findings thus provide a robust scientific rationale for developing Phocaeicola vulgatus as a next-generation psychobiotic and call for clinical trials to validate this promising therapeutic strategy for the emotional burden of IBS. Supplementary information Supplementary information Supplementary Table 1 Supplementary Table 2 Supplementary Table 3 Supplementary Table 4 Supplementary Table 5 Supplementary Table 6 Supplementary Table 7 Supplementary Table 8 Acknowledgements The schematic illustration in Fig. 7 was created in BioRender (https://biorender.com). Author contributions JCW, JH, K.LZ, DKW, and ZYX performed the research, analyzed the data, and wrote the manuscript. XML, PCY, WQ, LZ, and ZQL analyzed the data. XHH and TB designed the research study and revised the manuscript. The authors read and approved the final manuscript. Funding This work was supported by the National Key Research and Development Program of China (No. 2022YFC2504001), the National Natural Science Foundation of China (No. 92268108 and 81900477), and the Natural Science Foundation of Hubei Province (No. 2023AFB807). Data availability The full-length 16S rRNA sequencing and shotgun metagenomic sequencing data is available in the Sequence Read Archive (SRA) of National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/sra) with accession number PRJNA1329148 and PRJNA1335151, respectively. The data generated or analyzed during this study are included in this published article and its supplementary information files. Ethics approval and consent to participate This study involving human samples was approved by the Clinical Trial Ethics Committee of Huazhong University of Science and Technology (the Approval No. of the Ethics Committee is 2021-0814), and all the patients provided written informed consent. This trial was registered in Chinese Clinical Trials Registry (ChiCTR2200055171, Registered on January 2, 2022). All animal studies and experimental procedures were approved by the Institutional Animal Care and Use Committee, Tongji Medical College, Huazhong University of Science and Technology ([2025] IACUC Number: 4742). Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. These authors contributed equally: Jiacheng Wu, Jing He, Kailu Zhang. Contributor Information Xiaohua Hou, Email: houxh@hust.edu.cn. Bai Tao, Email: drbaitao@126.com, Email: baitao@wust.edu.cn. Supplementary information The online version contains supplementary material available at 10.1038/s41398-026-04142-y. References Associated Data Supplementary Materials Supplementary information Supplementary Table 1 Supplementary Table 2 Supplementary Table 3 Supplementary Table 4 Supplementary Table 5 Supplementary Table 6 Supplementary Table 7 Supplementary Table 8 Data Availability Statement The full-length 16S rRNA sequencing and shotgun metagenomic sequencing data is available in the Sequence Read Archive (SRA) of National Center for Biotechnology Information (NCBI) (https://www.ncbi.nlm.nih.gov/sra) with accession number PRJNA1329148 and PRJNA1335151, respectively. The data generated or analyzed during this study are included in this published article and its supplementary information files.